Eli Lilly Japan
Eli Lilly Japan researches, develops and supplies innovative medicines, working in diabetes, obesity, cancer, central nervous system disorders including Alzheimer's disease, and autoimmune disease. It is headquartered in Kobe, Hyogo, with a Tokyo branch and the Seishin plant, and its parent in Indianapolis, Indiana is Eli Lilly and Company.
Company Overview
日本イーライリリー株式会社
Pharmaceutical
Hyogo
2,724
Hiring Activity
- 22
- 1
- 4
Prior 30 days: 5
Tracked Since: July 2026